Report ID: SQSG35A2093
Report ID:
SQSG35A2093 |
Region:
Global |
Published Date: April, 2024
Pages:
157
|
Tables:
96 |
Figures:
76
Hyperbaric Oxygen Therapy Market size was valued at USD 34.5 Billion in 2023 and is poised to grow from USD 36.75 Billion in 2024 to USD 57.62 Billion by 2032, growing at a CAGR of 6.51% during the forecast period (2025-2032).
The hyperbaric oxygen therapy device plays an important role in various medical issues as it is a medical device that is used to provide an optimum level of oxygen to the tissues in the human body under high atmospheric pressure.
The air pressure, in this medical treatment, is increased two to three times higher than the normal air pressure. Thus, the oxygen-carrying blood helps to fight bacteria and other unwanted hosts in the body by promoting healing.
This medical treatment is used to treat wounds as a result of radiation, air bubbles in blood vessels, and many other serious infections like diabetes.
The Food and Drug Administration (FDA) has approved 13 medical uses of hyperbaric oxygen therapy (HBOT) to date. The regulatory has approved a number of indications such as pulmonary embolism, severe anaemia, decompression sickness, burns and brain abscesses to name a few out of the thirteen approved indications.
Another factor that is projected to accelerate the growth of the market include the huge price tag associated with hyperbaric oxygen therapy (HBOT) products.
US Hyperbaric Oxygen Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQSG35A2093